Skip to main content
OpenTrials
Completed

NCT Number: NCT03262597

"Beverage Hydration Index" of Commercial Therapeutic Beverages

The "beverage hydration index" (BHI) assesses the hydration potential of any consumable fluid relative to water. The BHI is a relatively new metric. Our purpose was to assess the BHI of beverages never previously tested, including an amino acid-based oral rehydration solution (AA-ORS), a glucose-containing ORS (G-ORS) and a sports drink (SD) compared to water (control).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sonoma State Univrsity

Rohnert Park, California, 94928, United States

About this study

The "Beverage Hydration Index" (BHI) was created to assess the degree to which beverages "hydrate", by measuring fluid retention after ingesting a 1 liter bolus and comparing it to water. Drinks with carbohydrates and electrolytes would traditionally be expected to score higher on the BHI due to glucose-sodium cotransport at the gut and osmolality approaching isotonicity with blood. One recent study reported that an oral rehydration solution (ORS) scored better than water, but a "sports drink" did not. No "optimal" BHI beverage composition has been described, nor has an optimal osmolality. Recently, a hypotonic amino acid-based rehydration beverage was developed to take advantage of amino acid-sodium cotransport, thus obviating the need for carbohydrate. However, the BHI of this beverage has not yet been assessed. The purpose of this investigation was to assess the hydration potential of this novel beverage in comparison to a commercially available carbohydrate-containing sports drink and oral rehydration solution.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy male or female
  • Aged 18-35
  • BMI 18-27 kg/m2
  • No known cardiovascular, renal or metabolic disease
  • Moderately active
  • Moderate alcohol use

Exclusion criteria

  • Overweight or obese (BMI >27 kg/m2)
  • Competitive athletes during competition season
  • Current or former cardiovascular, renal or metabolic disease
  • Habitual consumption of alcohol (>21 units/week) or regular (>1/week) high (10 units) intake*
  • History of psychiatric illness
  • Actively seeking to gain or lose weight
  • Currently taking prescribed medication
  • Example, a 750 ml bottle of wine at 12% ABV contains 0.750 Liters * 12 = 9 units

Treatment and study plan

enterade

Other

Subjects will consume enterade, which is an amino acid-based oral rehydration solution.

Pedialyte

Other

Subjects will consume Pedialyte

Gatorade

Other

Subjects will consume Gatorade

Water

Other

Subjects will consume water as the control beverage

Primary outcomes

  1. Beverage hydration index

    Time frame: 4 hours

    beverage hydration index

Sponsors and collaborators

Lead sponsor

Sonoma State University

Other

Collaborators

  • Entrinsic Bioscience Inc.

Registry information

Official study title

Beverage Hydration Index of Three Commercial Oral Rehydration Therapy ORT Beverages

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Aug 25, 2017
Registry last updated
Mar 7, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.